Results 21 to 30 of about 706,442 (245)

Is There a Relationship Between Use of Anti-Vascular Endothelial Growth Factor Agents and Atrophic Changes in Age-Related Macular Degeneration Patients?

open access: yesTürk Oftalmoloji Dergisi, 2018
Choroidal neovascularization due to age-related macular degeneration (AMD) is currently treated successfully with anti-vascular endothelial growth factor (VEGF) intravitreal agents.
Süleyman Kaynak   +2 more
doaj   +1 more source

Serum lipids in adults with late age-related macular degeneration: a case-control study

open access: yesLipids in Health and Disease, 2019
Background Lipids are implicated in the pathogenesis of age-related macular degeneration (AMD). The relationship between systemic lipids and AMD has not been well characterized.
Richard D. Semba   +12 more
doaj   +1 more source

Test–retest variability of microperimetry in geographic atrophy

open access: yesInternational Journal of Retina and Vitreous, 2020
Purpose Microperimetry (MP) allows for measurement of retinal sensitivity at precise locations and is now commonly employed as a clinical trial endpoint.
A. Yasin Alibhai   +7 more
doaj   +1 more source

Treating patients with geographic atrophy: are we there yet?

open access: yesInternational Journal of Retina and Vitreous, 2023
Geographic atrophy (GA) is a progressive degenerative disease that significantly contributes to visual impairment in individuals aged 50 years and older. The development of GA is influenced by various modifiable and non-modifiable risk factors, including
Bani Antonio-Aguirre   +1 more
doaj   +1 more source

Gray matter atrophy rate as a marker of disease progression in AD [PDF]

open access: yes, 2010
Global gray matter (GM) atrophy rates were quantified from magnetic resonance imaging (MRI) over 6- and 12-month intervals in 37 patients with Alzheimer's disease (AD) and 19 controls using: (1) nonlinear registration and integration of Jacobian values ...
Miller, David H.   +29 more
core   +1 more source

Living with Geographic Atrophy: An Ethnographic Study

open access: yesOphthalmology and Therapy, 2019
Introduction The specific impact from the patient’s perspective of geographic atrophy (GA), an advanced form of age-related macular degeneration (AMD), is not well understood.
Sobha Sivaprasad   +7 more
doaj   +1 more source

[Imaging diagostics of geographic atrophy] [PDF]

open access: yes, 2010
The development of imaging technologies has contributed to the understanding of the genesis and pathophysiological mechanisms of geographic atrophy (GA) secondary to age-related macular degeneration (AMD).
Wolf, S   +11 more
core   +1 more source

Development of Therapies for Spinal Muscular Atrophy Using Gene Therapy and Nanotechnology [PDF]

open access: yes, 2013
Spinal muscular atrophy (SMA) is a genetic disease which is characterized by muscle weakness and atrophy. The disease arises from mutations in the survival motor neuron 1 (SMN1) gene causing degeneration of spinal cord motor neurons.
Little, Daniel
core   +6 more sources

Retrospective hospital-based analysis of age-related macular degeneration patterns in India: 5-year follow-up

open access: yesIndian Journal of Ophthalmology, 2015
Purpose: To provide a detailed analysis of age-related macular degeneration (AMD) with a 5-year follow-up at a Tertiary Eye Care Center in India. Methods: In this retrospective institutional study, 408 eyes of 204 subjects (100 males) with a diagnosis of
Aditya Sudhalkar   +5 more
doaj   +1 more source

Methodological Appraisal of Phase 3 Clinical Trials in Geographic Atrophy

open access: yesBiomedicines, 2023
Geographic atrophy (GA) secondary to age-related macular degeneration is a common cause of blindness worldwide. Given the recent approval of the first therapy for GA, pegcetacoplan, we critically appraise methodological aspects of the phase 3 clinical ...
Marc Biarnés   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy